Annals of Medicine is an online, open access, international journal publishing across 33 areas of medicine and is part of our Elevate Series. This means that you will receive a concierge-level publishing experience, including dedicated support from our expert in-house Editorial team, with guaranteed response times of within 48 hours, an initial decision on whether your article will be peer reviewed within 5 working days, and a first decision on your research within an average of 22 working days.
The journal promotes collaboration across therapy areas and the open sharing of research. Combined with its scope covering translational medicine to clinical practice, Annals of Medicine is the home for researchers dedicated to supporting medical professionals in advancing practice for patients worldwide.
Accepting original research articles, review articles, clinical trials, protocols, case series and commentaries, the journal welcomes the submission of negative and null results, and reproducibility studies. Letters to the Editor are also considered and should discuss an analysis of an article previously published in Annals of Medicine.
Case reports are not accepted. Case series must review a minimum of 5 cases and will be considered where they provide novel insight on a disease or disease subtype.
When considering submission of a paper utilizing publicly available data, authors should ensure that such studies add significantly to the body of knowledge and that they are validated using the authors’ own data through replication in an original sample.
Pharmacological studies based solely on in silico analyses without experimental validation are not considered.
The journal welcomes submissions to the following sections: • Addiction
